Back to Search Start Over

4DMT links gene therapy to drop in Eylea injections, fueling plans to enter phase 3.

Authors :
Taylor, Nick Paul
Source :
FierceBiotech; 2/5/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

4DMT linked its gene therapy to a 90% reduction in treatment burden in wet AMD, emboldening it to start planning to enter phase 3 next year. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
GENE therapy
AFLIBERCEPT
INJECTIONS
ACID mine drainage

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
175281913

Tools

Authors Abstract Subjects Details